This is from the video posted on the website: [Geoffrey Kempler: So, we've just finished our phase one clinical trial, it was in about a little under 80 patients in multiple ascending doses, single ascending doses. The drug's proven to be very safe, so far.]
That is a pretty casual way to announce it. Maybe somebody needs some dementia treatmentI would call that price sensitive, and the ASX requires an announcement to the market. He said it is complete and that there were no problems. All good news. I guess that means even the very high doses are good so far.
Phase1 finished, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $8.4K | 2.1M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 67 | 79035427 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 115463117 | 7 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |